Patents by Inventor Xin-Zhuan Su

Xin-Zhuan Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS THAT TREAT MALARIA AND PREVENT MALARIA TRANSMISSION
    Publication number: 20160303103
    Abstract: The invention provides methods and compounds for the treatment and prevention of malaria infection and transmission in a mammal by administering compounds of the invention to a mammal having or suspected of having a malaria infection. The invention also provides pharmaceutical compositions that can kill or arrest the growth of Plasmodium organisms, and especially Plasmodium falciparum, thereby preventing or blocking transmission of malaria as well as treating malaria infection.
    Type: Application
    Filed: June 24, 2016
    Publication date: October 20, 2016
    Inventors: Xin-zhuan SU, Jing YUAN, Dipak RAJ, Sittiporn PATTARADILOKRAT, Ron JOHNSON, Ruili HUANG
  • Compounds that treat malaria and prevent malaria transmission
    Patent number: 9375424
    Abstract: The invention provides methods and compounds for the treatment and prevention of malaria infection and transmission in a mammal by administering compounds of the invention to a mammal having or suspected of having a malaria infection. The invention also provides pharmaceutical compositions that can kill or arrest the growth of Plasmodium organisms, and especially Plasmodium falciparum, thereby preventing or blocking transmission of malaria as well as treating malaria infection.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: June 28, 2016
    Assignee: The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Xin-zhuan Su, Jing Yuan, Dipak Raj, Sittiporn Pattaradilokrat, Ron Johnson, Ruili Huang
  • Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins
    Patent number: 6962987
    Abstract: The present invention provides isolated polypeptides useful in the treatment and prevention of malaria caused by Plasmodium falciparum or P. vivax. In particular, the polypeptides are derived from the binding domains of the proteins in the EBL family as well as the sialic acid binding protein (SABP) on P. falciparum merozoites. The polypeptides may also be derived from the Duffy antigen binding protein (DABP) on P. vivax merozoites.
    Type: Grant
    Filed: May 21, 2002
    Date of Patent: November 8, 2005
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Kim Lee Sim, Chetan Chitnis, Louis H. Miller, David S. Peterson, Xin-Zhuan Su, Thomas E. Wellems
  • Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte
    Publication number: 20020169305
    Abstract: The present invention provides isolated polypeptides useful in the treatment and prevention of malaria caused by Plasmodium falciparum or P. vivax. In particular, the polypeptides are derived from the binding domains of the proteins in the EBL family as well as the sialic acid binding protein (SABP) on P. falciparum merozoites. The polypeptides may also be derived from the Duffy antigen binding protein (DABP) on P. vivax merozoites.
    Type: Application
    Filed: May 21, 2002
    Publication date: November 14, 2002
    Inventors: Kim Lee Sim, Chetan Chitnis, Louis H. Miller, David S. Peterson, Xin-Zhuan Su, Thomas E. Wellems
  • Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
    Patent number: 6392026
    Abstract: The present invention provides isolated polypeptides useful in the treatment and prevention of malaria caused by Plasmodium falciparum or P. vivax. In particular, the polypeptides are derived from the binding domains of the proteins in the EBL family as well as the sialic acid binding protein (SABP) on P. falciparum merozoites. The polypeptides may also be derived from the Duffy antigen binding protein (DABP) on P. vivax merozoites.
    Type: Grant
    Filed: December 11, 1998
    Date of Patent: May 21, 2002
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Kim Lee Sim, Chetan Chitnis, Louis H. Miller, David S. Peterson, Xin-Zhuan Su, Thomas E. Wellems
  • Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
    Patent number: 5993827
    Abstract: The present invention provides isolated polypeptides useful in the treatment and prevention of malaria caused by Plasmodium falciparum or P. vivax. In particular, the polypeptides are derived from the binding domains of the proteins in the DBL family as well as the sialic acid binding protein (SABP) on P. falciparum merozoites. The polypeptides may also be derived from the Duffy antigen binding protein (DABP) on P. vivax merozoites.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 30, 1999
    Assignee: The United States of America as represented by the Secretary, Department of Health and Human Services
    Inventors: Kim Lee Sim, Chetan Chitnis, Louis H. Miller, David S. Peterson, Xin-Zhuan Su, Thomas E. Wellems
  • Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins
    Patent number: 5849306
    Abstract: The present invention provides isolated polypeptides useful in the treatment and prevention of malaria caused by Plasmodium falciparum or P. vivax. In particular, the polypeptides are derived from the binding domains of the proteins in the EBL family as well as the sialic acid binding protein (SABP) on P. falciparum merozoites. The polypeptides may also be derived from the Duffy antigen binding protein (DABP) on P. vivax merozoites.
    Type: Grant
    Filed: December 7, 1995
    Date of Patent: December 15, 1998
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Kim Lee Sim, Chetan Chitnis, Louis H. Miller, David S. Peterson, Xin-Zhuan Su, Thomas E. Wellems